Gene · 4973
NIH grants1,585
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,585
Download this page as JSON| Grant | Title | OLR1 papers | Newest fiscal year |
|---|---|---|---|
| R01EY024605 | Choriocapillaris Protection and Replacement in AMD | 1 | 2025 |
| R01GM074215 | Kinetochore Specification and Function | 1 | 2025 |
| R01GM108618 | Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal | 1 | 2025 |
| R01HD020676 | Trophoblast Differentiation | 1 | 2025 |
| R01HD034568 | Prenatal environmental determinants of health in young adulthood: a lifecourse approach | 1 | 2025 |
| R01HL113006 | Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling | 1 | 2025 |
| R01HL128239 | Genetic and molecular basis for SRSF2 mutations in myelodysplasia | 1 | 2025 |
| R01HL130020 | Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs | 1 | 2025 |
| R01HL130167 | SIRT6 and vascular endothelial homeostasis | 1 | 2025 |
| R01HL141371 | Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy | 1 | 2025 |
| R01HL141851 | Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs | 1 | 2025 |
| R01HL142214 | Coronary Endothelial Cell Dysfunction in Diabetes: Role of MFGE8 | 1 | 2025 |
| R01HL150266 | Inhibition of Radiation-Induced Coronary Microvascular Disease | 1 | 2025 |
| R01HL151651 | Functional and molecular consequences of SF3B1 mutations in human hematopoietic stem cells | 1 | 2025 |
| R01HL152090 | Immunomodulation of Galectin-3 to Prevent Radiation-Induced Myocardial Fibrogenesis | 1 | 2025 |
| R01HL157387 | Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit | 1 | 2025 |
| R01HL160661 | Metabolic regulation of hypercapnic chronic obstructive pulmonary disease (COPD)-driven skeletal muscle dysfunction | 1 | 2025 |
| R01HL161000 | Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis | 1 | 2025 |
| R01HL161071 | Red blood cell ATP export and transfusion in sepsis | 1 | 2025 |
| R01MD015407 | The role of epigenetics in the adverse effects of social environmental stressors on COPD outcomes | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/grants?page=9